These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1215542)

  • 1. Synthesis of dl-4,5,6-trinor-3,7-inter-m-phenylene-3oxaprostaglandins including one which inhibits platelet aggregation.
    Nelson NA; Jackson RW; Au AT; Wynalda DJ; Nishizawa EE
    Prostaglandins; 1975 Nov; 10(5):795-806. PubMed ID: 1215542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of 2-decarboxy-2-(tetrazol-5-yl) prostaglandins.
    Nelson NA; Jackson RW; Au AT
    Prostaglandins; 1975 Aug; 10(2):303-6. PubMed ID: 1178909
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandins and congeners XIII (1). The synthesis of dl-erythro-16-methoxyprostaglandins.
    Hallett WA; Wissner A; Grudzinskas CV; Partridge R; Birnbaum JE; Weiss MJ
    Prostaglandins; 1977 Mar; 13(3):409-15. PubMed ID: 847242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prostaglandin endoperoxide mimic, prostaglandin F2alpha acetal.
    Portoghese PS; Larson DL; Abatjoglou AG
    J Med Chem; 1977 Feb; 20(2):320-1. PubMed ID: 836508
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and biological evaluation of omega-homologues of prostaglandin E1.
    Dajani EZ; Rozek LF; Sanner JH; Miyano M
    J Med Chem; 1976 Aug; 19(8):1007-10. PubMed ID: 966245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
    Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
    [No Abstract]   [Full Text] [Related]  

  • 7. Designing prostacyclin analogues.
    Flohé L; Böhlke H; Frankus E; Kim SM; Lintz W; Loschen G; Michel G; Müller B; Schneider J; Seipp U
    Arzneimittelforschung; 1983; 33(9):1240-8. PubMed ID: 6315026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolysis of an orally active platelet inhibitory prostanoid amide in the plasma of several species.
    Honohan T; Fitzpatrick FA; Booth DG; McGrath JP; Morton DR; Nishizawa E
    Prostaglandins; 1980 Jan; 19(1):123-36. PubMed ID: 6770417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16-Fluoroprostaglandins.
    Magerlein BJ; Miller WL
    Prostaglandins; 1975 Apr; 9(4):527-30. PubMed ID: 1153808
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-specific prostaglandin antagonism by 8-ethoxycarbonyl-5-methyl-10, 11-dihydro-PGA1-ethyl ester (HR 546) on some smooth muscle preparations in vitro.
    Adaikan PG; Karim SM
    Prostaglandins; 1977 Oct; 14(4):653-7. PubMed ID: 594369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acid inhibits thromboxane synthesis in platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1978 Apr; 15(4):629-36. PubMed ID: 674694
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart.
    de Deckere EA; Nugteren DH; Ten Hoor F
    Nature; 1977 Jul; 268(5616):160-3. PubMed ID: 339097
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of activity of the acid, methyl ester and amide of an orally active platelet aggregation inhibitory prostanoid in the rat.
    Honohan T; Nishizawa EE; Douglas SL
    Prostaglandins; 1980 Jan; 19(1):139-53. PubMed ID: 7384535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.
    Bédi J; Blaskó G; Pálos LA
    Arzneimittelforschung; 1979; 29(9):1405-8. PubMed ID: 583250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation and white thrombus formation by prostaglandin analogue ONO-747.
    Ojima M; Fujita K
    Adv Prostaglandin Thromboxane Res; 1976; 2():781-5. PubMed ID: 983877
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandins and congeners. IX. The synthesis of 15-deoxy-16-, 17-, or 20-hydroxyprostaglandins and 15-deoxy-15-hydroxymethylprostaglandin E2.
    Floyd MB; Schaub RE; Weiss MJ
    Prostaglandins; 1975 Aug; 10(2):289-96. PubMed ID: 1178907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins V (1). Synthesis and pharmacology of (+/-)-11-deoxy-10-hydroxyprostaglandin E1 methyl ester.
    Caton MP; Darnbrough G; Hambling DJ; Jordon R; Parker T
    Prostaglandins; 1979 Oct; 18(4):569-76. PubMed ID: 531225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of PGA and PGB compounds on gastrointestinal tract smooth muscle from man and laboratory animals.
    Adaikan PG; Karim SM
    Prostaglandins; 1976 Jan; 11(1):15-22. PubMed ID: 1257494
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of some prostaglandin E1 analogues on guinea pig and human respiratory tract.
    Adaikan PG; Karim SM
    Prostaglandins; 1979 Nov; 18(5):787-91. PubMed ID: 542613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterization.
    Gorman RR; Sun FF; Miller OV; Johnson RA
    Prostaglandins; 1977 Jun; 13(6):1043-53. PubMed ID: 887795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.